6185 — Cansino Biologics Income Statement
0.000.00%
Last trade - 00:00- HK$8.29bn
- HK$7.03bn
- CNY824.88m
- 30
- 13
- 92
- 41
Annual income statement for Cansino Biologics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 18.5 | 4,300 | 1,031 | 345 | 825 |
| Cost of Revenue | |||||
| Gross Profit | 4.74 | 3,003 | -187 | -876 | 580 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 419 | 2,388 | 2,400 | 2,380 | 1,228 |
| Operating Profit | -401 | 1,912 | -1,369 | -2,035 | -403 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -397 | 1,937 | -1,184 | -1,979 | -381 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -397 | 1,907 | -965 | -1,967 | -384 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -397 | 1,914 | -909 | -1,483 | -379 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -397 | 1,914 | -909 | -1,483 | -379 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.72 | 7.73 | -3.68 | -6.01 | -1.35 |
| Dividends per Share |